Signature Wealth Management Group’s Thermo Fisher Scientific TMO Stock Holding History

Signature Wealth Management Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$993K	Buy	+2,020	New	+$1.1M	0.38%	67

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Signature Wealth Management Group's TMO Position: Q1 2026 in Review

Signature Wealth Management Group opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 2,020 shares worth $993K. The stake represents 0.38% of the portfolio and ranks #67 among its holdings.

2,606 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Signature Wealth Management Group held 2,020 shares of Thermo Fisher Scientific worth $993K as of Q1 2026.
Thermo Fisher Scientific was a new Signature Wealth Management Group position in Q1 2026.
Thermo Fisher Scientific made up 0.38% of Signature Wealth Management Group's portfolio in Q1 2026, its #67 holding.
2,606 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Signature Wealth Management Group's 13F filing for Q1 2026, filed 1 Apr 2026.